Opaleye Management Inc. Ayala Pharmaceuticals, Inc. Transaction History

Opaleye Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$9.2 - $11.3 $998,669 - $1.23 Million	-108,551 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$10.72 - $22.0 $1.16 Million - $2.39 Million	108,551 New	108,551 $1.18 Million

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.